Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Vrablik

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Current Atherosclerosis Reports|January 29, 2026
Pleiotropic Effects of Statins: Focus on Endothelial Function, Plaque Stability and Thrombosis (Part II)Ali Mahmoudi, Niki Katsiki, Michal Vrablik, et al.
Frontiers in Genetics|April 4, 2022
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical CharacteristicsTereza Altschmiedova, Veronika Todorovova, Michal Vrablik, et al.
Gynecologic and Obstetric Investigation|August 24, 2007
Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed studyTomas Fait, Michal Vrablik, Zdenek Zizka, et al.
Current Atherosclerosis Reports|January 10, 2026
Pleiotropic Effects of Statins: Focus on Inflammation, Oxidative Stress and Immunomodulation (Part I)Ali Mahmoudi, Niki Katsiki, Michal Vrablik, et al.
Atherosclerosis|November 9, 2023
Lipid-lowering in diabetes: An updateAlan Chait, Robert H Eckel, Michal Vrablik, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)Niki Katsiki, Michal Vrablik, Maciej Banach, et al.
Metabolism: Clinical and Experimental|July 22, 2008
Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteinsMichal Vrablik, Tomas Fait, Jan Kovar, et al.
Neuro Endocrinology Letters|November 28, 2012
The effect of coenzyme Q10 in statin myopathyLukas Zlatohlavek, Michal Vrablik, Barbora Grauova, et al.
International Journal of Molecular Sciences|April 30, 2021
Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?Michal Vrablik, Dana Dlouha, Veronika Todorovova, et al.
European Journal of Internal Medicine|March 11, 2015
Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech populationJaroslav A Hubacek, Vera Adamkova, Petra Hruba, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Current Atherosclerosis Reports|January 29, 2026
Pleiotropic Effects of Statins: Focus on Endothelial Function, Plaque Stability and Thrombosis (Part II)Ali Mahmoudi, Niki Katsiki, Michal Vrablik, et al.
Frontiers in Genetics|April 4, 2022
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical CharacteristicsTereza Altschmiedova, Veronika Todorovova, Michal Vrablik, et al.
Gynecologic and Obstetric Investigation|August 24, 2007
Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed studyTomas Fait, Michal Vrablik, Zdenek Zizka, et al.
Current Atherosclerosis Reports|January 10, 2026
Pleiotropic Effects of Statins: Focus on Inflammation, Oxidative Stress and Immunomodulation (Part I)Ali Mahmoudi, Niki Katsiki, Michal Vrablik, et al.
Atherosclerosis|November 9, 2023
Lipid-lowering in diabetes: An updateAlan Chait, Robert H Eckel, Michal Vrablik, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)Niki Katsiki, Michal Vrablik, Maciej Banach, et al.
Metabolism: Clinical and Experimental|July 22, 2008
Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteinsMichal Vrablik, Tomas Fait, Jan Kovar, et al.
Neuro Endocrinology Letters|November 28, 2012
The effect of coenzyme Q10 in statin myopathyLukas Zlatohlavek, Michal Vrablik, Barbora Grauova, et al.
International Journal of Molecular Sciences|April 30, 2021
Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?Michal Vrablik, Dana Dlouha, Veronika Todorovova, et al.
European Journal of Internal Medicine|March 11, 2015
Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech populationJaroslav A Hubacek, Vera Adamkova, Petra Hruba, et al.
Pageof 8